Medline Colorectal ME Convenience Kits Recall Over Sterility Breach in ChloraPrep Applicators

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Medline Industries is recalling 176 Colorectal ME convenience kits due to potential sterility breach in included BD ChloraPrep applicators.

The full picture behind this FDA recall

This notice was issued by FDA on September 15, 2026 and geographically references United States. The FDA classifies this as a Class II recall, with the stated reason "The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the sterile barrier is compromised, patients and users may be exposed to microbial contamination. Potential health consequences may include no injury, localized infection, or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization. In rare cases, particularly in critically ill or immunocompromised patients, severe infection could become life-threatening.", distributed us nationwide distribution.. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

A quick skim tells you whether this affects you directly; a closer read tells you more. Check the scope, the source, and how recent the record is, then weigh it against related notices rather than treating any single one as a trend.

Before acting, the primary agency source is available to check alongside this summary. Its related labels are recall, product-safety, fda, Devices.

What Happened

Medline Industries, LP initiated a voluntary recall of certain convenience kits after determining that the included BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators may have a compromised sterile barrier due to wrinkles in the paper lidding that could extend to the seal area.

Which Products Are Affected

The recall covers Medline Convenience Kits: COLORECTAL ME, Model Number DYNJ906437D. Affected lot numbers are 23LBL348, 24BBA259, 24BBN513, 24BBS350, and 24BBU576. A total of 176 kits were distributed nationwide in the United States. The recall number is Z-3052-2026.

What You Should Do

Customers should contact Medline Industries, LP for instructions regarding the recalled kits.

Why This Matters

If the sterile barrier is compromised, patients and users may be exposed to microbial contamination, which could result in localized infection or, less commonly, more serious infection requiring medical treatment.

Source

FDA recall Z-3052-2026, Medline Industries, LP, Northfield, IL.

Original source: FDA Official Notice ↗

All FDA Recalls →

Comparable nationwide notices (length or severity timing) 8

Two cross-category peer sets, both computed from Areazine's own archive: notices with a similar body length, and notices near the same severity and agency date. These are drawn from other categories, not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Medline Industries is recalling 176 Colorectal ME convenience kits due to potential sterility breach in included BD ChloraPrep applicators.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How is this recall classified, and why does that matter?
The FDA classifies this as a Class II recall, citing "The kits contain BD ChloraPrep Clear - 1 mL and FREPP Clear 1.5 mL Applicators which have a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the sterile barrier is compromised, patients and users may be exposed to microbial contamination. Potential health consequences may include no injury, localized infection, or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization. In rare cases, particularly in critically ill or immunocompromised patients, severe infection could become life-threatening." as the reason. Class I is the most serious (reasonable probability of serious harm), Class II is a moderate or temporary health risk, and Class III is unlikely to cause harm.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.